Insulet Securities Fraud Class Action
Analysis based on 301 articles · First reported Jul 02, 2026 · Last updated Aug 19, 2026
Insulet's stock price fell significantly upon disclosure of manufacturing issues, erasing billions in market value. The class action lawsuits may result in substantial financial liability for the company and further erode investor confidence.
Multiple law firms have filed securities fraud class action lawsuits against Insulet Corporation (NASDAQ: PODD) on behalf of investors who purchased Insulet securities between February 21, 2025 and May 26, 2026. The lawsuits allege that Insulet made false and misleading statements regarding its manufacturing controls and procedures, which were defective and created a risk that its products would violate safety regulations or cause injury. The truth emerged on March 12, 2026, when Insulet announced a voluntary Medical Device Correction for Omnipod 5 Pods due to a manufacturing issue, causing its stock to drop 6.9%. On May 26, 2026, Insulet announced another correction for multiple Omnipod products, causing a further 5.1% decline. Investors have until August 31, 2026 to seek lead plaintiff status. The case is pending in the United States — United States District Court for the Northern District of California.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard